Chloramphenicol + DexamethasoneThird Party Manufacturing in India

Chloramphenicol + Dexamethasone works through a dual mechanism where chloramphenicol acts as a broad-spectrum bacteriostatic antibiotic by binding to the bacterial 50S ribosomal subunit to stop protein translation, while dexamethasone acts as a potent anti-inflammatory corticosteroid by repressing leukocyte infiltration and cytokine gene expression. They target these biological pathways simultaneously to help the body eliminate bacterial ocular pathogens while reducing intense capillary dilation and pain. Unlike mono-antibiotics, it offers fast relief from visible swelling. It is highly effective and well-tolerated when used under medical supervision.

Therapeutic Uses

• Infectious Blepharoconjunctivitis: Indicated for superficial ocular bacterial infections where a strong concomitant anti-inflammatory effect is required.
• Anterior Uveitis and Post-Surgical Care: Used to control post-operative inflammation and prevent secondary bacterial colonization.

Why Manufacturers Choose Chloramphenicol + Dexamethasone

Chloramphenicol + Dexamethasone third party manufacturing in India remains an indispensable clinical product due to its widespread prescribing patterns in treating acute, highly symptomatic bacterial eye conditions. Celesta coordinates bulk batches via modern partner facilities that are WHO-GMP certified, ensuring strict liquid stability, perfect suspension micro-filtering, and optimized pH profiles. This classical combination is critical for establishing consistent revenue loops within institutional and generic supply chains operating under WHO-GMP standards.